arrow
J

Junji Saruwatari

kumamoto university
H指数:26
被引数:2,358

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Risk Assessment of Neutropenia Based on Exposure Information Without Plasma Concentration Measurement in Pemetrexed–Platinum-Based Chemotherapy: A Modeling Approach Using Real-World Clinical Data

基于暴露信息(无需血浆浓度测量)的培美曲塞-铂类为基础化疗中中性粒细胞减少风险评估:一项基于真实世界临床数据的建模方法

2026-08-010
OA
Sex-specific risk factors for genital infections associated with SGLT2 inhibitors in type 2 diabetes: a retrospective cohort study and disproportionality analysis using JADER

2型糖尿病中与SGLT2抑制剂相关的生殖器感染性别特异性危险因素:一项基于JADER的回顾性队列研究和不成比例性分析

2026-07-200
PRE
Effect of Cumulative Exposure on the Efficacy of Paroxetine: A Population Pharmacokinetic-Pharmacodynamic and Machine Learning Analyses

累积暴露对帕罗西汀疗效的影响:一项群体药代动力学-药效学分析和机器学习分析

2025-05-130
OA
Lymph node macrophage-targeted interferon alpha boosts anticancer immune responses by regulating CD169-positive phenotype of macrophages

淋巴节点巨噬细胞靶向干扰素α通过调控巨噬细胞CD169阳性表型增强抗肿瘤免疫反应

2025-05-030
OA
A MODELING APPROACH TO THE THERAPEUTIC EFFECT OF PAROXETINE FOR DEPRESSION WITH A FOCUS ON PHARMACOKINETICS- PHARMACODYNAMICS RELATIONSHIP

一种关注药代动力学-药效动力学关系的帕罗西汀治疗抑郁症的疗效建模方法

2025-02-120
OA
An orally available P1′-5-fluorinated Mpro inhibitor blocks SARS-CoV-2 replication without booster and exhibits high genetic barrier
2025-01-070
OAAI
Carbon monoxide-loaded cell therapy as an exercise mimetic for sarcopenia treatment

一氧化碳负载的细胞疗法作为肌肉减少症治疗的运动模拟物

2024-08-011
PRE
Identification of SARS-CoV-2 Mpro inhibitors containing P1' 4-fluorobenzothiazole moiety highly active against SARS-CoV-2
2023-02-2524
OAAI